Structure-Function Mapping of the Nuclear Pore Complex
核孔复合体的结构-功能图谱
基本信息
- 批准号:10394295
- 负责人:
- 金额:$ 66.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-03-01 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:BehaviorBindingCell NucleusCell physiologyChromatinCommunitiesComplexCytoplasmDNADefectDevelopmentDiseaseDissectionDrug DesignDrug TargetingElementsEpigenetic ProcessEukaryotic CellFoundationsFunctional disorderFutureGene ExpressionGene Expression ProfileGenesGenetic TranscriptionHumanKnowledgeLeadLightLinkMapsMediatingMessenger RNAMethodsMolecularMutationNatureNuclearNuclear EnvelopeNuclear Pore ComplexNuclear Pore Complex ProteinsNuclear StructureOncogenicOrthologous GenePathway interactionsPhenotypeProcessProtein ImportProteinsRegulationRegulator GenesResolutionRoleSignal TransductionSiteStructureTestingTherapeuticViralWorkYeastsdesignempoweredgenetic informationinsightmRNA Exportnucleocytoplasmic transportoutcome predictionpleiotropismvirtual
项目摘要
PROJECT SUMMARY (Abstract)
The Nuclear Pore Complex (NPC) is a large cylindrical assembly embedded in the nuclear envelope, central for
nuclear function at two related levels. First, as a regulator of transport, the NPC controls signalling access to the
DNA and the passage of genetic information from DNA. Second, the NPC is an important regulator of genes by
binding chromatin and its regulators to control expression states, a phenomenon that is poorly understood at the
molecular level. These pivotal roles in all eukaryotic cells involve dozens of interacting pathways influencing
virtually all aspects of cellular function. As a consequence, disruption of the NPC leads to many human disorders.
Despite this, and though the nuclear transport machinery is a valid and powerful drug target, the NPC and the
nuclear transport machinery have not been a significant part of therapeutic strategies. Arguably, there are two
fundamental reasons why this is the case: (i) we do not know enough about the structure of the NPC to predict
its behavior; (ii) the nuclear transport machinery impacts a bewildering array of cellular functions - thus even with
a deep understanding of its structure, we still require complementary functional information to be able to predict
the outcome of the targeted disruption of key elements of the transport pathway. We propose two Specific Aims
that inform each other in a synergistic fashion. First, we will perform structural mapping of disease-associated
Nup complexes, focusing on components of the cytoplasmic export platform and inner rings that have been
linked to oncogenic and developmental defects. We will use enhanced versions of the methods we have already
successfully deployed to generate high resolution maps of these two regions and their attachment sites. On
completion of this study, we will have mapped most of the NPC at high precision, allowing the two regions to be
seen in the context of the whole NPC assembly. Second, and in parallel, we will map the functions of disease-
associated Nup complexes. We will dissect the functionalities associated with the target Nup complexes, and
determine the defects associated with their alteration - testing the hypothesis that these Nups are linked to
diseases because their disruption alters critical gene expression patterns in a manner distinct from other
nucleoporins. Realizing these aims will generate NPC structure-function maps in unprecedented detail and which
are essential to understanding how different parts of the NPC act together to determine its functionality. This
project will shed light on the nature of numerous disorders associated with human NPC dysfunction; aimed
ultimately to open the nuclear transport machinery to rational and predictive drug design.
项目摘要(摘要)
核孔复合物(NPC)是嵌入核包膜中的大圆柱组件,中心
两个相关水平的核功能。首先,作为运输的调节器,NPC控制着信号访问到达
DNA和遗传信息从DNA传递。其次,NPC是基因的重要调节因子
结合染色质及其调节剂控制表达状态,这种现象在
分子水平。这些在所有真核细胞中的关键作用涉及数十个影响的相互作用的途径
实际上,细胞功能的所有方面。结果,NPC的破坏会导致许多人类疾病。
尽管如此,尽管核运输机械是有效而有力的药物靶标,但NPC和
核运输机制并不是治疗策略的重要组成部分。可以说有两个
这样就是这样的基本原因:(i)我们对NPC的结构不太了解
它的行为; (ii)核运输机制会影响一系列令人困惑的细胞功能 - 因此
对其结构有深刻的了解,我们仍然需要互补的功能信息才能预测
运输途径关键要素的目标破坏的结果。我们提出了两个具体目标
这是以协同的方式互相告知的。首先,我们将进行与疾病相关的结构映射
NUP复合物,重点关注细胞质出口平台的组件和内部环
与致癌和发育缺陷有关。我们将使用已有方法的增强版本
成功部署以生成这两个区域及其附件站点的高分辨率图。在
完成这项研究的完成,我们将以高精度绘制大部分NPC,从而使两个区域成为
在整个NPC组件的上下文中看到。第二,同时,我们将绘制疾病的功能 -
相关的NUP复合物。我们将剖析与目标NUP复合物相关的功能,并
确定与它们的变化相关的缺陷 - 测试这些NUP链接到的假设
疾病是因为它们的破坏以不同于其他的方式改变了关键基因表达模式
核孔蛋白。意识到这些目标将以前所未有的细节生成NPC结构功能地图以及哪些
对于了解NPC的不同部分如何共同确定其功能至关重要。这
项目将阐明与人类NPC功能障碍相关的众多疾病的性质;瞄准
最终,将核运输机制开放到理性和预测药物设计。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN D. AITCHISON其他文献
JOHN D. AITCHISON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN D. AITCHISON', 18)}}的其他基金
Applying the principle of synthetic lethality to virus-host protein-protein interactions as a novel approach for antiviral development
将合成致死原理应用于病毒-宿主蛋白质-蛋白质相互作用,作为抗病毒开发的新方法
- 批准号:
9253351 - 财政年份:2016
- 资助金额:
$ 66.62万 - 项目类别:
Applying the principle of synthetic lethality to virus-host protein-protein interactions as a novel approach for antiviral development
将合成致死原理应用于病毒-宿主蛋白质-蛋白质相互作用,作为抗病毒开发的新方法
- 批准号:
9102845 - 财政年份:2016
- 资助金额:
$ 66.62万 - 项目类别:
Structure-Function Mapping of the Nuclear Pore Complex
核孔复合体的结构-功能图谱
- 批准号:
9024590 - 财政年份:2015
- 资助金额:
$ 66.62万 - 项目类别:
Structure-Function Mapping of the Nuclear Pore Complex
核孔复合体的结构-功能图谱
- 批准号:
9430429 - 财政年份:2015
- 资助金额:
$ 66.62万 - 项目类别:
Structure-Function Mapping of the Nuclear Pore Complex-Renewal
核孔复合体更新的结构-功能图谱
- 批准号:
10658474 - 财政年份:2015
- 资助金额:
$ 66.62万 - 项目类别:
Structure-Function Mapping of the Nuclear Pore Complex
核孔复合体的结构-功能图谱
- 批准号:
8888675 - 财政年份:2015
- 资助金额:
$ 66.62万 - 项目类别:
Structure-Function Mapping of the Nuclear Pore Complex
核孔复合体的结构-功能图谱
- 批准号:
9922914 - 财政年份:2015
- 资助金额:
$ 66.62万 - 项目类别:
TR&D Project 2. The Analysis Stage I: Tools for Analyzing the Composition and Stoichiometry of Macromolecular Assemblies
TR
- 批准号:
10621356 - 财政年份:2014
- 资助金额:
$ 66.62万 - 项目类别:
TR&D Project 2. The Analysis Stage I: Tools for Analyzing the Composition and Stoichiometry of Macromolecular Assemblies
TR
- 批准号:
10401761 - 财政年份:2014
- 资助金额:
$ 66.62万 - 项目类别:
相似国自然基金
精子细胞核周RNA结合蛋白(STRBP)促进三阴性乳腺癌进展的功能及机制研究
- 批准号:82173275
- 批准年份:2021
- 资助金额:54.7 万元
- 项目类别:面上项目
近端结合CRISPR探针构建及细胞核基因点突变直接成像研究
- 批准号:21904119
- 批准年份:2019
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
食管癌细胞核中微丝结合捆绑蛋白Fascin的功能及其分子作用机制研究
- 批准号:81902469
- 批准年份:2019
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
特异性结合PLK1基因的新型肿瘤细胞核靶向型吡咯-咪唑类聚酰胺的设计、合成与生物活性研究
- 批准号:21977111
- 批准年份:2019
- 资助金额:66 万元
- 项目类别:面上项目
可变多聚腺苷酸化在细胞核内的功能
- 批准号:31800689
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Novel application of pharmaceutical AMD3100 to reduce risk in opioid use disorder: investigations of a causal relationship between CXCR4 expression and addiction vulnerability
药物 AMD3100 降低阿片类药物使用障碍风险的新应用:CXCR4 表达与成瘾脆弱性之间因果关系的研究
- 批准号:
10678062 - 财政年份:2023
- 资助金额:
$ 66.62万 - 项目类别:
Regulation of paraspeckles by STAU1 in neurodegenerative disease
STAU1 在神经退行性疾病中对 paraspeckles 的调节
- 批准号:
10668027 - 财政年份:2023
- 资助金额:
$ 66.62万 - 项目类别:
Localized mitochondrial metabolic activity in Xenopus mesendoderm cells undergoing collective cell migration
爪蟾中内胚层细胞集体细胞迁移的局部线粒体代谢活性
- 批准号:
10751722 - 财政年份:2023
- 资助金额:
$ 66.62万 - 项目类别:
Full Project 1: Defining Mechanisms of MICAL-dependent Pancreatic Cancer Cell Migration
完整项目 1:MICAL 依赖性胰腺癌细胞迁移的定义机制
- 批准号:
10762273 - 财政年份:2023
- 资助金额:
$ 66.62万 - 项目类别:
The role of the protocadherin gene cluster in neurodevelopment and the implications for neurodevelopmental disorders
原钙粘蛋白基因簇在神经发育中的作用及其对神经发育障碍的影响
- 批准号:
10808516 - 财政年份:2023
- 资助金额:
$ 66.62万 - 项目类别: